Working… Menu

Treatment of Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03712930
Recruitment Status : Terminated (Sponsor's decision to revisit the development approach for prostate cancer.)
First Posted : October 19, 2018
Last Update Posted : September 23, 2020
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 6, 2020
Actual Study Completion Date : August 6, 2020